DBD vs MA

For growth investors, Mastercard Incorporated (MA) is the stronger pick with 16.

4% revenue growth year-over-year, versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). Mastercard Incorporated (MA) offers the better valuation at 30. 3x trailing P/E (25. 5x forward), making it the more compelling value choice. Analysts rate Diebold Nixdorf, Incorporated (DBD) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Mastercard Incorporated (MA) is the cheapest at 30.

3x versus Diebold Nixdorf, Incorporated at 31. 1x. On forward P/E, Diebold Nixdorf, Incorporated is actually cheaper at 14. 4x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Diebold Nixdorf, Incorporated (DBD) delivered a total return of +283.

4%, compared to +36. 8% for Mastercard Incorporated (MA). Over 10 years, the gap is even starker: MA returned +437. 2% versus DBD's +289. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Mastercard Incorporated (MA) is the lower-risk stock at 0.

67β versus Diebold Nixdorf, Incorporated's 1. 21β — meaning DBD is approximately 82% more volatile than MA relative to the S&P 500. On balance sheet safety, Diebold Nixdorf, Incorporated (DBD) carries a lower debt/equity ratio of 106% versus 2% for Mastercard Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Mastercard Incorporated (MA) is pulling ahead at 16.

4% versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). On earnings-per-share growth, the picture is similar: Diebold Nixdorf, Incorporated grew EPS 677. 3% year-over-year, compared to 18. 9% for Mastercard Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Mastercard Incorporated (MA) is the more profitable company, earning 45.

6% net margin versus 2. 5% for Diebold Nixdorf, Incorporated — meaning it keeps 45. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MA leads at 59. 2% versus 8. 8% for DBD. At the gross margin level — before operating expenses — MA leads at 83. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Diebold Nixdorf, Incorporated (DBD) trades at 14.

4x forward P/E versus 25. 5x for Mastercard Incorporated — 11. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MA: 31. 1% to $656. 87.

In this comparison, MA (0.

6% yield) pays a dividend. DBD does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Mastercard Incorporated (MA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

67), 0. 6% yield, +437. 2% 10Y return). Both have compounded well over 10 years (MA: +437. 2%, DBD: +289. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (DBD (Technology) and MA (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: DBD is a small-cap quality compounder stock; MA is a large-cap high-growth stock. MA pays a dividend while DBD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.